Full Text View
Tabular View
No Study Results Posted
Related Studies
Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers
This study is not yet open for participant recruitment.
Verified by Syracuse University, May 2008
First Received: May 15, 2008   Last Updated: May 16, 2008   History of Changes
Sponsored by: Syracuse University
Information provided by: Syracuse University
ClinicalTrials.gov Identifier: NCT00680147
  Purpose

This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.


Condition Intervention Phase
HPV
Behavioral: brief informational intervention to promote HPV vaccine acceptance
Phase II

U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Open Label, Single Group Assignment, Efficacy Study
Official Title: HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers

Further study details as provided by Syracuse University:

Primary Outcome Measures:
  • completed vaccination with Gardasil [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • assessed cross-sectionally, at time of initial enrollment [ Time Frame: assessed at time of baseline assessment ] [ Designated as safety issue: No ]

Estimated Enrollment: 600
Study Start Date: July 2008
Estimated Study Completion Date: March 2010
Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: brief informational intervention to promote HPV vaccine acceptance
    Teen and parent participants will receive a brief informational intervention that provides basic facts about the HPV vaccine, including the health benefits and three-dose requirements, along with information regarding where to go to receive the vaccination. A coupon for a free HPV vaccination will provided to the parent for use by their teenage daughter.
Detailed Description:

The HPV vaccine offers hope that the incidence of cervical cancer can be greatly reduced in the U.S. and globally. However, because the vaccine is recommended for children and early adolescents, vaccine awareness and acceptance among parents is critical to insuring vaccine uptake and public health benefit. Although culturally specific concerns may reduce HPV vaccination among African-American youth, research has not addressed this possibility.

Accordingly, the proposed study will enroll 300 mothers in a study to identify barriers to HPV vaccination among low-income, African-American teens.

Surveys assessing culturally-specific barriers to HPV vaccination acceptance will be administered to both parents and their vaccine-eligible children.

Upon completion of the survey, parents with vaccine-eligible daughters will be invited to receive a free HPV vaccination for their child through a local, teen-friendly health clinic. Outcome analyses will focus on identification of predictors of completed vaccinations among girls and barriers to vaccine acceptance among mothers of teenage sons. Our study will provide critically important behavioral outcome data linking barriers to vaccination to subsequent vaccination decisions in a real-world, health care setting.

  Eligibility

Ages Eligible for Study:   11 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Females parent or guardian with an African-American daughter or son between the ages of 11 and 17
  • African-American adolescents between the ages of 11-17
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00680147

Contacts
Contact: Peter A Vanable 315-443-1210 pvanable@syr.edu

Locations
United States, New York
Center for Health and Behavior, Syracuse University
Syracuse, New York, United States, 13244
Sponsors and Collaborators
Syracuse University
  More Information

Additional Information:
No publications provided

Responsible Party: Syracuse University ( Peter A. Vanable, Associate Professor )
Study ID Numbers: IISP ID# 33546
Study First Received: May 15, 2008
Last Updated: May 16, 2008
ClinicalTrials.gov Identifier: NCT00680147     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by Syracuse University:
HPV
Gardasil
African-American
adolescent
health behavior
sexually transmitted infections
This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.

Study placed in the following topic categories:
Sexually Transmitted Diseases

ClinicalTrials.gov processed this record on May 07, 2009